Skip to content

Exposure-based Treatment for Avoidant Back Pain Patients

Exposure Therapy in Chronic Low Back Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01484418
Acronym
ETABP
Enrollment
68
Registered
2011-12-02
Start date
2011-08-31
Completion date
2017-08-31
Last updated
2017-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Chronic Low Back Pain, Cognitive Behavioural Therapy, Exposure, Fear avoidance, Cognitive Behavioural Therapy in chronic low back pain, Exposure in vivo in chronic low back pain

Brief summary

Chronic low back pain often results in psychosocial and physical disability. A subgroup of these patients shows fear of (re)injury and avoidance behaviour leading to higher disability. The purpose of this study is to determine whether exposure in vivo is more effective in the treatment of fear avoidant chronic back pain patients than psychological treatment as usual (cognitive behavioural psychotherapy).

Interventions

5-10 sessions based on an individualized fear hierarchy

graded activity, relaxation techniques and cognitive interventions

Sponsors

Psychotherapie-Ambulanz Marburg e.V.
CollaboratorOTHER
German Research Foundation
CollaboratorOTHER
Philipps University Marburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Having at least 3 months back pain * Sufficient level on fear avoidance scores (TSK, Phoda) * Being German-speaking * Agreeing to participate, verified by completion of informed consent

Exclusion criteria

* Red flags * Pregnancy * Illiteracy * Psychoses * Alcohol addiction * surgeries during the last 6 months or planed surgeries * Specific medical disorders or cardiovascular diseases preventing participation in physical exercise * Participating in another psychotherapy

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in pain severity at 3 and 6 months after admissionfrom Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)Numeric Rating Scale (NRS)
Change from baseline in pain disability at 3 and 6 months after admissionfrom Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)Pain Disability Index (PDI) Quebec Back Pain Disability Scale (QBPDS)

Secondary

MeasureTime frameDescription
Change in emotional distress from Pretest to two in-between timepoints to Posttest to Follow-upfrom Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)Hospital Anxiety and Depression Scale (HADS)
Change in fear avoidance from Pretest to two in-between time points to Posttestfrom Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)Tampa Scale of Kinesiophobia (TSK) Pain Anxiety Symptom Scale (PASS)
Change in physical activity from Pretest to two in-between timepoints to Posttest to Follow-up Timefrom Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)International Physical Activity Questionnaire(IPAQ)
Change in quality of life from Pretest to two in-between timepoints to Posttest to Follow-upfrom Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)EuroQol (EQ-5D)
Change in pain catastrophizing from Pretest to two in-between timepoints to Posttest to Follow-upfrom Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)Pain Catastrophizing Scale (PCS)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026